Freedom Capital initiated coverage of Heartflow with a Buy rating and $37 price target. Healthcare AI is one of the fastest-growing technology segments, says the analyst, who found that the majority of generative AI spend in healthcare is flowing to startups rather than large incumbent HCIT companies. HeartFlow is one of the most widely adopted imaging AI solutions, specializing in coronary artery disease diagnosis, risk stratification, and treatment planning. Its AI-powered platform, Heartflow One, integrates with coronary CT angiography to create dynamic, personalized 3D models of the heart, the analyst tells investors.
